In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Walgreen's WHP pilot study encourages testing for H. pylori in high-risk patients.

Executive Summary

WALGREEN's WHP H. PYLORI EDUCATION PILOT STUDY will assess cost-effectiveness of Walgreen's pharmacy benefit management subsidiary WHP Health Initiatives' approach to encourage testing for treatment of ulcers caused by Helicobacter pylori, WHP Managed Care Pharmacy Resident Mark Matusik told the Academy of Managed Care annual meeting in New Orleans May 9. WHP Health Initiatives surveyed 5,062 patients chosen from Walgreen's pharmacy database on the basis of long-term use of acid-lowering drugs. Forty-five percent of patients responded.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel